Apolipoprotein E Gene and Functional MRI
NCT01287819 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2019-09-19
Summary
1. Apolipoprotein E gene (ApoE) is the most important genetic factor for Alzheimer disease (AD) and an important genetic factor for outcome of brain injury situations.
2. Function magnetic resonance imaging (fMRI) is a powerful tool for study of both brain regional functions and brain network.
3. Study about genetic contribution on fMRI is an emerging concept, which will help on understanding about how the genetics affecting the brain function.
Conditions
Sponsors & Collaborators
-
Chang Gung Memorial Hospital
collaborator OTHER -
Taipei Medical University Shuang Ho Hospital
lead OTHER
Principal Investigators
-
Chaur-Jong Hu, M.D. · Taipei Medical University Shuang Ho Hospital
Eligibility
- Min Age
- 45 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2013-04-17
- Completion
- 2013-04-18
Countries
- Taiwan
Study Locations
More Related Trials
-
Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease
NCT04174287 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Apolipoprotein E on the Prognosis of Patients With Intracerebral Hemorrhage
NCT05687201 ·Status: COMPLETED
-
Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain
NCT04692441 ·Status: RECRUITING ·Phase: NA
-
Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)
NCT02759887 ·Status: COMPLETED ·Phase: NA
-
Multimodal Biomarkers for Diagnosis and Prognosis in CAA
NCT03969732 ·Status: UNKNOWN ·Phase: PHASE3
-
Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study
NCT02018913 ·Status: UNKNOWN
-
Metabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET
NCT07100470 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Detecting Early Alzheimer's Using MR
NCT05614310 ·Status: RECRUITING
-
Multi-modal Neuroimaging in Alzheimer's Disease IMAP+
NCT01638949 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease
NCT00249080 ·Status: COMPLETED
-
Multimodal Biomarkers for Diagnosis and Prognosis in VCI
NCT04604600 ·Status: UNKNOWN ·Phase: PHASE3
-
Cerebral Substrates of Prospective Memory in Young and Its Disruption in Normal Aging and in Alzheimer's Disease: A Study in Anatomical MRI, Diffusion Tensor MRI and Functional MRI
NCT02522091 ·Status: UNKNOWN ·Phase: NA
-
Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study
NCT03588468 ·Status: COMPLETED ·Phase: NA
-
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
NCT06561906 ·Status: RECRUITING
-
PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)
NCT02062099 ·Status: COMPLETED ·Phase: PHASE1
-
The Influence of Sequential Tau Protein and Amyloid Plaque Imaging Changes on Stroke Prognosis and Cognitive Outcome
NCT04572477 ·Status: UNKNOWN ·Phase: PHASE2
-
Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease
NCT07114224 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
[18F]AV45(Aβ) and [18F]AV1451(Tau)PET/CT in the Diagnosis of Early Pathological Changes of Alzheimer's Disease
NCT06833645 ·Status: RECRUITING
-
Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old
NCT02198586 ·Status: COMPLETED
-
Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease Diagnosis
NCT05020626 ·Status: RECRUITING
-
Optimization and Harmonization of Advanced MRI Sequences
NCT06217237 ·Status: COMPLETED
-
ApoE Genotyping Analysis in Patients with Suspected Non-haemorrhagic Amyloid Angiopathy
NCT06809062 ·Status: NOT_YET_RECRUITING
-
FluoroAv45 Imaging Research-in Alzheimer's Disease
NCT01325259 ·Status: COMPLETED ·Phase: PHASE2
-
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621 ·Status: COMPLETED
-
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
NCT05582200 ·Status: RECRUITING